{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:50:55Z","timestamp":1762005055315,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":35,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783662586464"},{"type":"electronic","value":"9783662586471"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/8904_2018_136","type":"book-chapter","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:09:33Z","timestamp":1540199373000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Acute and Chronic Management in an Atypical Case of Ethylmalonic Encephalopathy"],"prefix":"10.1007","author":[{"given":"Thomas M.","family":"Kitzler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indra R.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Osterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Poulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannis","family":"Trakadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula J.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela C.","family":"Buhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"136_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"KR Atkuri","year":"2007","unstructured":"Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA (2007) N-Acetylcysteine \u2013 a safe antidote for cysteine\/glutathione deficiency. Curr Opin Pharmacol 7:355\u2013359","journal-title":"Curr Opin Pharmacol"},{"key":"136_CR2","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1007\/s10545-015-9877-x","volume":"38","author":"P Bherer","year":"2015","unstructured":"Bherer P, Cyr D, Buhas D, Al-Hertani W, Maranda B, Waters PJ (2015) Acylglycine profiling: a new liquid chromatography-tandem mass spectrometry (LC-MS\/MS) method, applied to disorders of organic acid, fatty acid, and ketone metabolism. J Inherit Metab Dis 38:S35\u2013S378","journal-title":"J Inherit Metab Dis"},{"key":"136_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ymgme.2018.02.008","volume":"124","author":"M Boyer","year":"2018","unstructured":"Boyer M, Sowa M, Di Meo I et al (2018) Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy. Mol Genet Metab 124:57\u201363","journal-title":"Mol Genet Metab"},{"key":"136_CR4","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1161\/ATVBAHA.110.209783","volume":"30","author":"M Bucci","year":"2010","unstructured":"Bucci M, Papapetropoulos A, Vellecco V et al (2010) Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30:1998\u20132004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"136_CR5","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/0140-6736(91)92338-3","volume":"338","author":"A Burlina","year":"1991","unstructured":"Burlina A, Zacchello F, Dionisi-Vici C et al (1991) New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet 338:1522\u20131523","journal-title":"Lancet"},{"key":"136_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.15252\/emmm.201505040","volume":"7","author":"I Meo Di","year":"2015","unstructured":"Di Meo I, Lamperti C, Tiranti V (2015) Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches. EMBO Mol Med 7:1257\u20131266","journal-title":"EMBO Mol Med"},{"key":"136_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/brain\/aww013","volume":"139","author":"C Dionisi-Vici","year":"2016","unstructured":"Dionisi-Vici C, Diodato D, Torre G et al (2016) Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease. Brain 139:1045\u20131051","journal-title":"Brain"},{"key":"136_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1399-0004.2010.01457.x","volume":"79","author":"A Drousiotou","year":"2011","unstructured":"Drousiotou A, DiMeo I, Mineri R, Georgiou T, Stylianidou G, Tiranti V (2011) Ethylmalonic encephalopathy: application of improved biochemical and molecular diagnostic approaches. Clin Genet 79:385\u2013390","journal-title":"Clin Genet"},{"key":"136_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/cbf.1618","volume":"28","author":"DJ Elsey","year":"2010","unstructured":"Elsey DJ, Fowkes RC, Baxter GF (2010) Regulation of cardiovascular cell function by hydrogen sulfide (H(2)S). Cell Biochem Funct 28:95\u2013106","journal-title":"Cell Biochem Funct"},{"key":"136_CR10","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s00415-002-0880-4","volume":"249","author":"S Grosso","year":"2002","unstructured":"Grosso S, Mostardini R, Farnetani MA et al (2002) Ethylmalonic encephalopathy: further clinical and neuroradiological characterization. J Neurol 249:1446\u20131450","journal-title":"J Neurol"},{"key":"136_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3109\/15563650.2015.1100305","volume":"53","author":"SH Hernandez","year":"2015","unstructured":"Hernandez SH, Howland M, Schiano TD, Hoffman RS (2015) The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies. Clin Toxicol (Phila) 53:941\u2013949","journal-title":"Clin Toxicol (Phila)"},{"key":"136_CR12","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1111\/j.1742-4658.2008.06482.x","volume":"275","author":"TM Hildebrandt","year":"2008","unstructured":"Hildebrandt TM, Grieshaber MK (2008) Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J 275:3352\u20133361","journal-title":"FEBS J"},{"key":"136_CR13","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1021\/bi300778t","volume":"51","author":"MR Jackson","year":"2012","unstructured":"Jackson MR, Melideo SL, Jorns MS (2012) Human sulfide:quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite. Biochemistry 51:6804\u20136815","journal-title":"Biochemistry"},{"key":"136_CR14","doi-asserted-by":"publisher","first-page":"44561","DOI":"10.1074\/jbc.M112.407411","volume":"287","author":"O Kabil","year":"2012","unstructured":"Kabil O, Banerjee R (2012) Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism. J Biol Chem 287:44561\u201344567","journal-title":"J Biol Chem"},{"key":"136_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11011-016-9928-5","volume":"32","author":"M Kilic","year":"2017","unstructured":"Kilic M, Dedeoglu O, Gocmen R, Kesici S, Yuksel D (2017) Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine. Metab Brain Dis 32:293\u2013296","journal-title":"Metab Brain Dis"},{"key":"136_CR16","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1096\/fj.04-1815fje","volume":"18","author":"Y Kimura","year":"2004","unstructured":"Kimura Y, Kimura H (2004) Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18:1165\u20131167","journal-title":"FASEB J"},{"key":"136_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.61.4.570","volume":"61","author":"KA McGowan","year":"2004","unstructured":"McGowan KA, Nyhan WL, Barshop BA et al (2004) The role of methionine in ethylmalonic encephalopathy with petechiae. Arch Neurol 61:570\u2013574","journal-title":"Arch Neurol"},{"key":"136_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00228-014-1802-y","volume":"71","author":"D Meulendijks","year":"2015","unstructured":"Meulendijks D, Khan S, Koks CH, Huitema AD, Schellens JH, Beijnen JH (2015) Baclofen overdose treated with continuous venovenous hemofiltration. Eur J Clin Pharmacol 71:357\u2013361","journal-title":"Eur J Clin Pharmacol"},{"key":"136_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/jmg.2008.058271","volume":"45","author":"R Mineri","year":"2008","unstructured":"Mineri R, Rimoldi M, Burlina AB et al (2008) Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. J Med Genet 45:473\u2013478","journal-title":"J Med Genet"},{"key":"136_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1096\/fj.03-1052fje","volume":"18","author":"Y Nagai","year":"2004","unstructured":"Nagai Y, Tsugane M, Oka J, Kimura H (2004) Hydrogen sulfide induces calcium waves in astrocytes. FASEB J 18:557\u2013559","journal-title":"FASEB J"},{"key":"136_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/01.MIB.0000225330.38119.c7","volume":"12","author":"M Perencevich","year":"2006","unstructured":"Perencevich M, Burakoff R (2006) Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 12:651\u2013664","journal-title":"Inflamm Bowel Dis"},{"key":"136_CR22","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1093\/hmg\/ddv007","volume":"24","author":"I Pettinati","year":"2015","unstructured":"Pettinati I, Brem J, McDonough MA, Schofield CJ (2015) Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy. Hum Mol Genet 24:2458\u20132469","journal-title":"Hum Mol Genet"},{"key":"136_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/0883073808331359","volume":"24","author":"N Pigeon","year":"2009","unstructured":"Pigeon N, Campeau PM, Cyr D, Lemieux B, Clarke JT (2009) Clinical heterogeneity in ethylmalonic encephalopathy. J Child Neurol 24:991\u2013996","journal-title":"J Child Neurol"},{"key":"136_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbrc.2004.02.176","volume":"317","author":"Z Qingyou","year":"2004","unstructured":"Qingyou Z, Junbao D, Weijin Z, Hui Y, Chaoshu T, Chunyu Z (2004) Impact of hydrogen sulfide on carbon monoxide\/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun 317:30\u201337","journal-title":"Biochem Biophys Res Commun"},{"key":"136_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/sdi.12400","volume":"28","author":"JK Roberts","year":"2015","unstructured":"Roberts JK, Westphal S, Sparks MA (2015) Iatrogenic baclofen neurotoxicity in ESRD: recognition and management. Semin Dial 28:525\u2013529","journal-title":"Semin Dial"},{"key":"136_CR26","volume-title":"Metabolic, toxic, and epileptic encephalopathies","author":"R Sutter","year":"2018","unstructured":"Sutter R, Pang T, Kaplan PW (2018) Metabolic, toxic, and epileptic encephalopathies. Wolters Kluwer, Alphen aan den Rijn"},{"key":"136_CR27","first-page":"57","volume":"11","author":"AR Tavasoli","year":"2017","unstructured":"Tavasoli AR, Rostami P, Ashrafi MR, Karimzadeh P (2017) Neurological and vascular manifestations of ethylmalonic encephalopathy. Iran J Child Neurol 11:57\u201360","journal-title":"Iran J Child Neurol"},{"key":"136_CR28","doi-asserted-by":"publisher","first-page":"a011437","DOI":"10.1101\/cshperspect.a011437","volume":"5","author":"V Tiranti","year":"2013","unstructured":"Tiranti V, Zeviani M (2013) Altered sulfide (H(2)S) metabolism in ethylmalonic encephalopathy. Cold Spring Harb Perspect Biol 5:a011437","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"136_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1086\/381653","volume":"74","author":"V Tiranti","year":"2004","unstructured":"Tiranti V, D\u2019Adamo P, Briem E et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239\u2013252","journal-title":"Am J Hum Genet"},{"key":"136_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/jmg.2005.036210","volume":"43","author":"V Tiranti","year":"2006","unstructured":"Tiranti V, Briem E, Lamantea E et al (2006) ETHE1 mutations are specific to ethylmalonic encephalopathy. J Med Genet 43:340\u2013346","journal-title":"J Med Genet"},{"key":"136_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nm.1907","volume":"15","author":"V Tiranti","year":"2009","unstructured":"Tiranti V, Viscomi C, Hildebrandt T et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200\u2013205","journal-title":"Nat Med"},{"key":"136_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.2188","volume":"16","author":"C Viscomi","year":"2010","unstructured":"Viscomi C, Burlina AB, Dweikat I et al (2010) Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16:869\u2013871","journal-title":"Nat Med"},{"key":"136_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1471-4159.2004.02617.x","volume":"90","author":"M Whiteman","year":"2004","unstructured":"Whiteman M, Armstrong JS, Chu SH et al (2004) The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite \u2018scavenger\u2019? J Neurochem 90:765\u2013768","journal-title":"J Neurochem"},{"key":"136_CR34","first-page":"175","volume":"60","author":"M Xu","year":"2008","unstructured":"Xu M, Wu YM, Li Q, Wang X, He RR (2008) Electrophysiological effects of hydrogen sulfide on pacemaker cells in sinoatrial nodes of rabbits. Sheng Li Xue Bao 60:175\u2013180","journal-title":"Sheng Li Xue Bao"},{"key":"136_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1055\/s-2007-984447","volume":"38","author":"DI Zafeiriou","year":"2007","unstructured":"Zafeiriou DI, Augoustides-Savvopoulou P, Haas D et al (2007) Ethylmalonic encephalopathy: clinical and biochemical observations. Neuropediatrics 38:78\u201382","journal-title":"Neuropediatrics"}],"container-title":["JIMD Reports","JIMD Reports, Volume 45"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2018_136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:58:17Z","timestamp":1557485897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2018_136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783662586464","9783662586471"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/8904_2018_136","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"type":"print","value":"2192-8304"},{"type":"electronic","value":"2192-8312"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"1 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"1 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"17 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"23 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}